Making sense of your Mounjaro plan: what the treatment actually involves

Is a Mounjaro plan the right starting point for you?

Before anything else, this is a clinical question, not a commercial one. Tirzepatide is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above where at least one weight-related condition is present, things like hypertension, dyslipidaemia, obstructive sleep apnoea or prediabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber looks at the full picture: your medical history, current medicines, any contraindications, and what you are hoping treatment will do for you. BMI alone does not determine approval.

If you are wondering how tirzepatide compares with other licensed options before committing, our weight-loss treatment overview sets out the landscape clearly. For those who have already decided and want the specifics of titration and pen use, the Mounjaro treatment page covers the clinical detail. And if cost is part of your decision, there is an honest breakdown on our UK Mounjaro cost page, worth reading before you start comparing headline prices across providers.

One quick habit worth building before you order from any online pharmacy: look them up on the GPhC register. It takes under a minute and tells you whether the pharmacy is legally registered to dispense prescription medicines. It is the single most useful check a patient can run.

What does a structured Mounjaro plan actually involve week by week?

The treatment runs in dose stages, each lasting roughly four weeks. The 2.5mg first pen is there to settle your digestive system into the change, the aim is tolerability, and most people notice the appetite shift more once they move up. From there, a prescriber reviews your progress and symptoms before each increase, stepping through 5mg, 7.5mg, 10mg and 12.5mg toward the 15mg maintenance dose if that is what your clinical picture supports. Not everyone reaches the top; the right dose for you is whichever one delivers meaningful progress without unacceptable side effects.

Throughout the plan, the injection itself is once a week, on the same day each week, into the abdomen, thigh or upper arm with the site rotated. Storage is in the fridge at 2–8°C, most people keep it in the fridge door. If you travel regularly, our page on flying with Mounjaro covers what the evidence and guidance say about transporting the pen safely. For everyday eating on treatment, practical menu planning on Mounjaro addresses the questions our prescribers are asked most often, protein adequacy, managing reduced appetite, and what to do when a favourite meal suddenly feels unappealing.

The NHS tirzepatide medicines page notes that the most common side effects are gastrointestinal: nausea, loose stools, indigestion, constipation and burping tend to cluster around dose increases and ease for most people within one to two weeks. NHS guidance on tirzepatide has a plain-English side-effect list worth bookmarking.

How does the clinical evidence frame realistic expectations?

The SURMOUNT-1 trial (2,539 adults with obesity, no diabetes, 72 weeks) reported average body-weight reductions of around 20–21% at the 15mg dose. That is the headline from one of the largest tirzepatide trials, published in the New England Journal of Medicine. The range across participants was wide: some lost considerably less, some considerably more. These are averages from a clinical trial population, and real-world results depend heavily on adherence, the dietary changes you make alongside treatment, and whether your dose reaches therapeutic levels.

NICE's appraisal of tirzepatide (TA1026) looked at this evidence base in detail and recommended it for NHS use within a defined eligibility framework. The private route (through a regulated pharmacy like ours) works to the same licensed eligibility criteria, without the NHS waiting list. If you want to understand the full tirzepatide treatment journey from eligibility through to dose review, that page maps it out step by step. And if you are already familiar with semaglutide and weighing up the two, our tirzepatide overview addresses the mechanistic differences directly.

One thing the evidence consistently shows: the plan works best as a structured programme, not a short-term fix. Appetite returns if treatment stops, which is why the conversation with your prescriber about long-term strategy matters as much as the starting dose.

What the plan looks like through a regulated UK pharmacy

At nume, a Mounjaro plan starts with a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber (a real clinician, not an automated system) who checks your suitability against the full clinical picture. Photo-ID verification and live weight confirmation by video are part of every assessment. If approved that same day, orders placed before 12pm are dispatched for free next-working-day DPD delivery in plain packaging.

Each repeat order goes through a fresh clinical review; our prescribers do not simply rubber-stamp continuations. If you have questions between doses, the FAQs section covers the most common ones, or the support team is available seven days a week. For anyone putting together the practicalities of a longer plan (what a month looks like, how to manage eating habits alongside the pen) the Mounjaro weight-loss plan guide and our treatment plans overview both sit alongside this page as practical next steps.

When you are ready to discuss whether this is the right plan for you, speak to our prescribers through a free consultation at a time that suits you.